AtriCure (ATRC) Research & Development (2016 - 2025)
Historic Research & Development for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $22.9 million.
- AtriCure's Research & Development rose 921.76% to $22.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.7 million, marking a year-over-year increase of 3370.52%. This contributed to the annual value of $96.2 million for FY2024, which is 3011.97% up from last year.
- Per AtriCure's latest filing, its Research & Development stood at $22.9 million for Q3 2025, which was up 921.76% from $29.3 million recorded in Q2 2025.
- Over the past 5 years, AtriCure's Research & Development peaked at $35.0 million during Q4 2024, and registered a low of $11.2 million during Q1 2021.
- Over the past 5 years, AtriCure's median Research & Development value was $17.4 million (recorded in 2023), while the average stood at $18.5 million.
- In the last 5 years, AtriCure's Research & Development crashed by 319.32% in 2021 and then skyrocketed by 6809.48% in 2024.
- AtriCure's Research & Development (Quarter) stood at $13.8 million in 2021, then dropped by 0.43% to $13.7 million in 2022, then soared by 51.27% to $20.8 million in 2023, then skyrocketed by 68.09% to $35.0 million in 2024, then crashed by 34.51% to $22.9 million in 2025.
- Its Research & Development stands at $22.9 million for Q3 2025, versus $29.3 million for Q2 2025 and $22.5 million for Q1 2025.